Term ends Jan 15, 2028 · High confidence
20-year base term ends Oct 10, 2027
Held by Cardiff Oncology, Inc.
Filed Apr 30, 2015 as application 14/701,265 · Granted Mar 6, 2018
Base term plus 97 days of patent term adjustment (USPTO delay)
Today
2007
2028
Clock starts
Oct 10, 2007
Oct 10, 2007
Term ends
Jan 15, 2028
Jan 15, 2028
Granted
Mar 6, 2018
Mar 6, 2018
base term
patent term adjustment
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
97
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,163,229, to Jan 15, 2028. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 97 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 10, 2007, when application 11/974,016, the earliest non-provisional in its chain, was filed (this one was filed Apr 30, 2015) | Oct 10, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +97 days, USPTO patent term adjustment record | Jan 15, 2028 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,163,229) | resolves to Jan 15, 2028, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 15, 2028 | High confidence |
This family
| US 9,163,229 | In force Jul 2028 | Jul 2028 |
| US 9,909,118 | this patent Jan 2028 | Jan 2028 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 2, 2015 Reel 35551, frame 570 | Umansky, Samuil R; Melkonyan, Hovsep; Meyer, Erik; Feaver, William John | Xenomics, Inc. | Assignment of Assignor's Interest |
| May 2, 2015 Reel 35551, frame 579 | Xenomics, Inc. | Trovagene, Inc. | Merger |
| Jun 22, 2020 Reel 53006, frame 379 | Trovagene, Inc. | Cardiff Oncology, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2028
Term ends Jan 15, 2028. No further fees fall due before then
Note
The 97 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 9,163,229, ends no earlier than this term, so it caps nothing.
Citations
1
later US patent cites this one
That is below the median of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.